(Q34460747)

2 August 2017

1 reference

title

Future vaccines: recent advances and future prospects (English)

1 reference

2 August 2017

Coffin SE

1

1 reference

2 August 2017

publication date

1 December 2001

1 reference

Primary Care: Clinics in Office Practice

2 August 2017

published in

1 reference

2 August 2017

volume

28

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

869-87, vii-viii

1 reference

Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Potential impact of low efficacy HIV-1 vaccines in populations with high rates of infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Phase 1 trial of a candidate rotavirus vaccine (RV3) derived from a human neonate

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Influenza Immunization for Children

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Colonization with penicillin-resistant Streptococcus pneumoniae in a child-care center.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Rotavirus Vaccines: Current Controversies and Future Directions

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Advances in influenza virus vaccine research

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Pneumococcal conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against Lyme disease in children

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Serious morbidity and mortality associated with influenza epidemics

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Therapeutic vaccines in HIV.1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Construction of four double gene substitution human x bovine rotavirus reassortant vaccine candidates: each bears two outer capsid human rotavirus genes, one encoding P serotype 1A and the other encoding G serotype 1, 2, 3, or 4 specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Prevention of otitis media in children by pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine Is Immunogenic in Infants and Children

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Safety and immunogenicity of three doses of a five-valent pneumococcal conjugate vaccine in children younger than two years with and without human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Pneumococcal resistance to antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Influenza surveillance in community-dwelling elderly compared with children.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Estimating household and community transmission parameters for influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Guarded endorsement for Lyme disease vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Impact of rotavirus infection at a large pediatric hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Fecal antibody responses to symptomatic and asymptomatic rotavirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

The cost effectiveness of vaccinating against Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Hypertrophy, hyperplasia, and infectious virus in gut-associated lymphoid tissue of mice after oral inoculation with simian-human or bovine-human reassortant rotaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

The Protective Effectiveness of Natural Rotavirus Infection in an American Indian Population

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Serum opsonic activity in infants with sickle-cell disease immunized with pneumococcal polysaccharide protein conjugate vaccine. The Pneumococcal Conjugate Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Rotaviruses: immunological determinants of protection against infection and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Intranasal influenza vaccine: adding to the armamentarium for influenza control

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Influenza immunization of schoolchildren: can we interrupt community epidemics?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Safety and Immunogenicity of an Outer Surface Protein A Vaccine in Subjects with Previous Lyme Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Lyme disease: a review of aspects of its immunology and immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Tick-borne diseases in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

1 reference

7 January 2021

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Cost-effectiveness analysis of a rotavirus immunization program for the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Immunization with recombinant p17/p24:Ty virus-like particles in human immunodeficiency virus-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Rotavirus infection in infants as protection against subsequent infections

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Protection against Rotavirus Disease after Natural Rotavirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

Differing virulence of H1N1 and H3N2 influenza strains

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970045-2

7 January 2021

10.1016/S0095-4543(05)70045-2

Identifiers

DOI

1 reference

release_yzdfes4guzdbfiejbgflkvbfja

2 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yzdfes4guzdbfiejbgflkvbfja

24 November 2022

mapped directly with Wikidata item

1 reference